JPS5833202B2 - ガンカヨウシヨホウノ アンテイカホウ - Google Patents

ガンカヨウシヨホウノ アンテイカホウ

Info

Publication number
JPS5833202B2
JPS5833202B2 JP49029246A JP2924674A JPS5833202B2 JP S5833202 B2 JPS5833202 B2 JP S5833202B2 JP 49029246 A JP49029246 A JP 49029246A JP 2924674 A JP2924674 A JP 2924674A JP S5833202 B2 JPS5833202 B2 JP S5833202B2
Authority
JP
Japan
Prior art keywords
oxotremorine
dehydro
gankayoushiyohouno
anteikahou
pilocarpine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49029246A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5035320A (fr
Inventor
レイモンド スミシーズ ジヨン
ジヤガンナス ラジヤドハイアクシヤ ビタル
ジエング デア フランク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00341732A external-priority patent/US3824313A/en
Application filed by Allergan Pharmaceuticals Inc filed Critical Allergan Pharmaceuticals Inc
Publication of JPS5035320A publication Critical patent/JPS5035320A/ja
Publication of JPS5833202B2 publication Critical patent/JPS5833202B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
JP49029246A 1973-03-16 1974-03-15 ガンカヨウシヨホウノ アンテイカホウ Expired JPS5833202B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00341732A US3824313A (en) 1973-03-16 1973-03-16 Topical opthalmic composition and methods of use
US44568574A 1974-02-25 1974-02-25

Publications (2)

Publication Number Publication Date
JPS5035320A JPS5035320A (fr) 1975-04-04
JPS5833202B2 true JPS5833202B2 (ja) 1983-07-18

Family

ID=26992634

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49029246A Expired JPS5833202B2 (ja) 1973-03-16 1974-03-15 ガンカヨウシヨホウノ アンテイカホウ

Country Status (7)

Country Link
JP (1) JPS5833202B2 (fr)
CA (1) CA1024070A (fr)
DE (1) DE2411019C2 (fr)
DK (1) DK136884B (fr)
ES (1) ES424362A1 (fr)
FR (1) FR2221140B1 (fr)
GB (1) GB1459264A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107759771A (zh) 2010-09-30 2018-03-06 索尔维公司 天然来源的环氧氯丙烷的衍生物
US20210369686A1 (en) * 2018-10-06 2021-12-02 Biotheravision Llc Ophthalmic preparations of muscarinic agonist and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444171A (en) * 1964-07-03 1969-05-13 Astra Apotekarnes Kem Fab Acetylenic imides and method for their preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444171A (en) * 1964-07-03 1969-05-13 Astra Apotekarnes Kem Fab Acetylenic imides and method for their preparation

Also Published As

Publication number Publication date
FR2221140B1 (fr) 1977-07-01
ES424362A1 (es) 1976-10-16
AU6679074A (en) 1975-09-18
CA1024070A (fr) 1978-01-10
DE2411019C2 (de) 1986-11-20
JPS5035320A (fr) 1975-04-04
DE2411019A1 (de) 1974-09-26
FR2221140A1 (fr) 1974-10-11
GB1459264A (en) 1976-12-22
DK136884B (da) 1977-12-12

Similar Documents

Publication Publication Date Title
JP5174777B2 (ja) Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
US4127674A (en) Method of treatment for glaucoma
JP2016515520A (ja) 併用療法
CA2506464C (fr) Medicament contre le glaucome comprenant un inhibiteur de la rho-kinase et un .beta.-bloquant
EP1889620A1 (fr) Gouttes oculaires contenant du roflumilast
US4197301A (en) Topical ophthalmic use of Prazosin
US5438060A (en) Method of reducing elevated intraocular pressure
US3885047A (en) Ocular hypotensive process employing dextrorotatory phenethanolamines
US4275074A (en) Catecholamine treatment of ocular hypertension
US3985897A (en) Ocular hypotensive process employing dextrorotatory sulfonamidophenethanolamines
EP0081581B1 (fr) Compositions de traitement du glaucome
US3991206A (en) Alleviation of eye inflammation by topical application of p-biphenylacetic acid
JPS5833202B2 (ja) ガンカヨウシヨホウノ アンテイカホウ
US4590210A (en) Compositions for treatment of ocular hypertension
JPS588013A (ja) 緑内障および高眼圧症の治療用薬学的調合物
US3920824A (en) Stable ophthalmic formulation
JP4300347B2 (ja) ブナゾシンとプロスタグランジン類からなる緑内障治療剤
US3670087A (en) Method of lowering intraocular pressure
US3933998A (en) 4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure lowering process
US3824313A (en) Topical opthalmic composition and methods of use
EP1200079B1 (fr) Derives de 2-aminotetraline destines au traitement du glaucome
JPH05221873A (ja) 鼻および目に局所使用するためのブラジキニン拮抗剤含有薬学的組成物
EP0728480A1 (fr) Utilisation d'ifenprodil pour le traitement de la pression intraoculaire élevée
EP0067910B1 (fr) Composés et compositions pour le traitement de l'hypertension oculaire
WO1980000215A1 (fr) Remede contre le glaucome